Literature DB >> 2301645

Regional hemodynamic effects of neuromedin U in conscious rats.

S M Gardiner1, A M Compton, T Bennett, J Domin, S R Bloom.   

Abstract

In conscious unrestrained Long-Evans rats, chronically instrumented with miniaturized pulsed Doppler flow probes, intravenous administration of porcine neuromedin U-8 by bolus (0.1 and 1.0 nmol) or infusion (1 and 10 nmol/h) exerted potent constrictor effects on the superior mesenteric vascular bed. With the choice of an appropriate dose, the reduction in superior mesenteric blood flow was not accompanied by any changes in systemic arterial blood pressure, heart rate, and renal or hindquarters blood flows. Porcine neuromedin U-25 had similar effects to neuromedin U-8, but was generally more potent. In Brattleboro rats the pattern of response to neuromedin U-25 was similar to that seen in Long-Evans rats, indicating that mesenteric vasoconstriction was not dependent on release of endogenous vasopressin. In Long-Evans rats the regional hemodynamic actions of rat neuromedin U were comparable with those of porcine neuromedin U-25. The latter peptide at a dose of 1.0 nmol caused a rise in total peripheral resistance and a reduction in cardiac output, with an inconsistent change in heart rate. The results raise the possibility that the high concentration of neuromedin U in the rat intestine is associated with the control of local blood flow.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301645     DOI: 10.1152/ajpregu.1990.258.1.R32

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis.

Authors:  Julia E Gambone; Stephanie S Dusaban; Roxana Loperena; Yuji Nakata; Susan E Shetzline
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

2.  Identification of neuromedin S and its possible role in the mammalian circadian oscillator system.

Authors:  Kenji Mori; Mikiya Miyazato; Takanori Ida; Noboru Murakami; Ryota Serino; Yoichi Ueta; Masayasu Kojima; Kenji Kangawa
Journal:  EMBO J       Date:  2005-01-06       Impact factor: 11.598

3.  Identification of G protein-coupled receptors for Drosophila PRXamide peptides, CCAP, corazonin, and AKH supports a theory of ligand-receptor coevolution.

Authors:  Yoonseong Park; Young-Joon Kim; Michael E Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

Review 4.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

5.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.

Authors:  Jane Gartlon; Philip Szekeres; Mark Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil Elshourbagy; Mark Duxon; Tracey E Ashmeade; David C Harrison; Paul Murdock; Shelagh Wilson; Abdel Ennaceur; Alan Atkins; Christian Heidbreder; Jim J Hagan; A Jackie Hunter; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

6.  Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.

Authors:  Clodagh E Prendergast; Magda F Morton; Katherine W Figueroa; Xiaodong Wu; Nigel P Shankley
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

7.  Moniezia benedeni infection enhances neuromedin U (NMU) expression in sheep (Ovis aries) small intestine.

Authors:  Wan-Ling Yao; Li-Ping Liu; Yan-Qiao Wen; Bao-Shan Wang; Jia-Qi Dong; Wan-Hong He; Xi-Ping Fan; Wen-Hui Wang; Wang-Dong Zhang
Journal:  BMC Vet Res       Date:  2022-04-19       Impact factor: 2.792

8.  Structural insights into the peptide selectivity and activation of human neuromedin U receptors.

Authors:  Chongzhao You; Yumu Zhang; Peiyu Xu; Sijie Huang; Wanchao Yin; H Eric Xu; Yi Jiang
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.